5’-transfer RNA halve-lysine-CTT as a promising biomarker for early detection of hepatocellular carcinoma
The 5'-tiRNA-Lys-CTT levels were higher in early HCC patients. 5'-tiRNA-Lys-CTT is a promising diagnostic biomarker for early-stage HCC and may play an oncogenic role in HCC by interacting with downstream mRNA targets <i>via</i> specific pathways.
Authors
- Shaoqing Ju (ORCID: https://orcid.org/0000-0001-7448-2020)
- Xianjuan Shen (ORCID: https://orcid.org/0000-0002-7002-9058)
- Wenchao Gu (ORCID: https://orcid.org/0000-0002-1505-9887)
- Lei Shen (ORCID: https://orcid.org/0000-0003-4040-8716)
- Xian Li (ORCID: https://orcid.org/0000-0002-9526-9031)
- Yan Zhang (ORCID: https://orcid.org/0000-0003-2479-7555)
- Jie Yuan
- Tianxin Xu
Institutions
- Nantong University (CN)
- Affiliated Hospital of Nantong University (CN)
Publication Details
- Journal
- World Journal of Gastrointestinal Oncology
- Published
- 2025-11-12
- DOI
- https://doi.org/10.4251/wjgo.v17.i11.111142
- Citations
- 1
- Primary Topic
- RNA modifications and cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.81